Dysport botulinum regulatory update

Ipsen said FDA pushed back the PDUFA date for a BLA for Dysport botulinum toxin type A to treat cervical dystonia by 3 months to Dec. 28 from Sept. 29 after FDA requested the company submit a Risk Com...